[go: up one dir, main page]

CN106967716A - Double gRNA, double gRNA libraries, double gRNA vector libraries and its preparation method and application - Google Patents

Double gRNA, double gRNA libraries, double gRNA vector libraries and its preparation method and application Download PDF

Info

Publication number
CN106967716A
CN106967716A CN201610312039.6A CN201610312039A CN106967716A CN 106967716 A CN106967716 A CN 106967716A CN 201610312039 A CN201610312039 A CN 201610312039A CN 106967716 A CN106967716 A CN 106967716A
Authority
CN
China
Prior art keywords
grna
double
library
sequence
promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610312039.6A
Other languages
Chinese (zh)
Inventor
丁先锋
莫寅元
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University of Technology ZJUT
Original Assignee
Zhejiang University of Technology ZJUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University of Technology ZJUT filed Critical Zhejiang University of Technology ZJUT
Priority to CN201610312039.6A priority Critical patent/CN106967716A/en
Publication of CN106967716A publication Critical patent/CN106967716A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/02Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/06Biochemical methods, e.g. using enzymes or whole viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a kind of couple of gRNA, double gRNA libraries, double gRNA vector libraries and its preparation method and application.This couple of gRNA is sequentially connected with and formed by the first promoter, gRNA a, crRNA stent sequence, the second promoter and gRNA b.This pair of gRNA library includes the multiple couples of gRNA for target gene.This pair of gRNA vector library is formed by connecting by this pair of gRNA library with carrier.In double gRNA of the present invention, gRNA a and gRNA b control it independently to express by different promoters respectively, and respectively with two target site complementary pairings on target gene, this this couple of gRNA to recruit Cas9 nucleases to shear target gene in two sgRNA action sites, effectively improve the knockout efficiency of target gene.

Description

双gRNA、双gRNA文库、双gRNA载体文库及其制备方法和应用Double gRNA, double gRNA library, double gRNA carrier library and preparation method and application thereof

技术领域technical field

本发明属于基因工程领域,具体涉及一种双gRNA、双gRNA文库、双gRNA载体文库及其制备方法和应用。The invention belongs to the field of genetic engineering, and in particular relates to a double gRNA, a double gRNA library, a double gRNA carrier library and a preparation method and application thereof.

背景技术Background technique

众所周知,蛋白质编码基因的转录只占全基因组转录的大约2%,其余的转录则均为非编码RNA如microRNA和lncRNA的转录。其中,lncRNA被定义为一组分子量大于200个核苷酸长度的非编码RNAs,越来越多的研究表明,LncRNA可能在各种机制中作为主要基因调控者,lncRNA表达的紊乱通常与多种人类疾病,如癌症,密切相关。It is well known that the transcription of protein-coding genes only accounts for about 2% of the whole genome transcription, and the rest of the transcription is the transcription of non-coding RNA such as microRNA and lncRNA. Among them, lncRNA is defined as a group of non-coding RNAs with a molecular weight greater than 200 nucleotides in length. More and more studies have shown that lncRNA may serve as the main gene regulator in various mechanisms, and the disorder of lncRNA expression is usually associated with a variety of Human diseases, such as cancer, are closely related.

到目前为止,已经有超过50,000的lncRNA被发现,这比蛋白质编码基因的数量要多得多,这也为我们人类基因组的复杂性提供了进一步证据。lncRNA是新型癌症生物标志物或治疗靶点的丰富来源,而且绝大部分lncRNA的生物学功能还是未知,对lncRNA进行功能性研究非常重要。So far, more than 50,000 lncRNAs have been discovered, far more than the number of protein-coding genes, providing further evidence of the complexity of our human genome. lncRNAs are a rich source of new cancer biomarkers or therapeutic targets, and the biological functions of most lncRNAs are still unknown, so it is very important to conduct functional research on lncRNAs.

目前最常用的基因功能性研究平台是通过RNA干扰(RNAi)对细胞中的目标基因进行敲除,特异性剔除或关闭特定基因的表达,然后检测干扰结果,通过分析该干扰结果了解相关基因的功能。At present, the most commonly used gene functional research platform is to knock out target genes in cells through RNA interference (RNAi), specifically knock out or turn off the expression of specific genes, and then detect the interference results, and understand the relevant genes by analyzing the interference results. Function.

遗憾的是,RNAi主要在细胞质中发挥功能性作用,而RISC复合物也位于细胞质中。然而许多lncRNA都位于细胞核中,这大大增加了通过RNA干扰敲除lncRNA的难度。同时,RNAi存在以下不足:(1)很难进行“回复实验”,因为外源性的配对物也受到RNAi试剂的约束;(2)敲除效率不高,极易出现高水平的假阴性表达,尤其在shRNA载体中。因此寻找新的基因功能性研究方法具有十分重大的意义。Unfortunately, RNAi primarily functions functionally in the cytoplasm, where the RISC complex is also located. However, many lncRNAs are located in the nucleus, which greatly increases the difficulty of knocking out lncRNAs by RNA interference. At the same time, RNAi has the following disadvantages: (1) It is difficult to carry out "reversion experiment", because the exogenous counterpart is also constrained by the RNAi reagent; (2) The knockout efficiency is not high, and high-level false negative expression is very easy to occur , especially in shRNA vectors. Therefore, it is of great significance to find new methods for gene functional research.

CRISPR/Cas9(Clustered Regularly Interspaced Short PalindromicRepeats)是最新出现的一种由RNA指导的Cas9核酸酶对靶向基因进行编辑的技术。CRISPR/Cas9是细菌和古细菌为应对病毒和质粒不断攻击而演化来的获得性免疫防御机制,在这一系统中,crRNA(CRISPR-derivedRNA)通过碱基配对与tracrRNA(trans-activating RNA)结合形成双链RNA,此tracrRNA/crRNA二元复合体指导Cas9蛋白在crRNA引导序列靶定位点切断双链DNA。在基因组编辑过程中,tracrRNA和crRNA可以融合成为1条RNA(single guide RNA,简称sgRNA)表达,sgRNA同样可以起到靶向剪切的作用。sgRNA的序列中含有一段固定序列(即crRNA支架序列)和一段目的DNA识别序列,其中目的DNA识别序列可与目的基因两条链中的其中一条进行碱基互补配对,而固定序列则用于招募Cas9核酸酶。CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats) is a newly emerged technology for editing targeted genes by RNA-guided Cas9 nuclease. CRISPR/Cas9 is an adaptive immune defense mechanism evolved by bacteria and archaea in response to the constant attack of viruses and plasmids. In this system, crRNA (CRISPR-derived RNA) combines with tracrRNA (trans-activating RNA) through base pairing Forming double-stranded RNA, this tracrRNA/crRNA binary complex guides the Cas9 protein to cut double-stranded DNA at the target site of the crRNA guide sequence. During the genome editing process, tracrRNA and crRNA can be fused into one RNA (single guide RNA, referred to as sgRNA) for expression, and sgRNA can also play the role of targeted cleavage. The sequence of sgRNA contains a fixed sequence (i.e. crRNA scaffold sequence) and a target DNA recognition sequence, wherein the target DNA recognition sequence can perform base pairing with one of the two strands of the target gene, and the fixed sequence is used to recruit Cas9 nuclease.

鉴于CRISPR/Cas9系统的高效性,针对蛋白质编码基因的敲除是比较容易的,因为一个微小的碱基缺失或插入就可以破坏开放阅读框,从而导致功能性基因产物的不表达。然而,非编码基因尤其是lncRNA的情况则十分不同,一个小的碱基缺失或者插入不一定会导致lncRNA功能缺失,如何对CRISPR/Cas9基因编辑技术进行进一步改进、以实现对包括lncRNA在内的所有基因或遗传元件的高效敲除是目前研究需要思考和解决的问题。Given the high efficiency of the CRISPR/Cas9 system, knockout of protein-coding genes is relatively easy, because a small base deletion or insertion can destroy the open reading frame, resulting in non-expression of functional gene products. However, the situation of non-coding genes, especially lncRNAs, is very different. A small base deletion or insertion does not necessarily lead to the loss of lncRNA function. How to further improve the CRISPR/Cas9 gene editing technology to realize The efficient knockout of all genes or genetic elements is a problem that needs to be considered and solved in current research.

发明内容Contents of the invention

本发明提供了一种双gRNA,该双gRNA比sgRNA分子具有更高的敲除效率。The present invention provides a double gRNA, which has a higher knockout efficiency than sgRNA molecules.

一种双gRNA(dual gRNA),由第一启动子、gRNA-a、crRNA支架序列、第二启动子和gRNA-b顺次连接而成。一个双gRNA分子靶向作用于相同的基因或遗传元件,其中,gRNA-a和gRNA-b分别由不同的启动子控制其独立表达,并分别与同一靶基因上的两个靶位点互补配对。从而该双gRNA能够招募Cas9核酸酶在两个sgRNA作用位点对靶基因进行剪切,大大提高了靶基因的敲除效率。A double gRNA (dual gRNA) is formed by sequentially linking the first promoter, gRNA-a, crRNA scaffold sequence, the second promoter and gRNA-b. A double gRNA molecule targets the same gene or genetic element, where gRNA-a and gRNA-b are independently expressed by different promoters and are complementary to two target sites on the same target gene . Therefore, the double gRNA can recruit Cas9 nuclease to cut the target gene at the two sgRNA action sites, greatly improving the knockout efficiency of the target gene.

本发明还提供了一种双gRNA文库,该双gRNA文库包括针对靶基因的多个双gRNA,所述双gRNA的序列结构为:第一启动子-(gRNA-na)-crRNA支架序列-第二启动子-(gRNA-nb);The present invention also provides a double gRNA library, the double gRNA library includes a plurality of double gRNA for the target gene, the sequence structure of the double gRNA is: the first promoter-(gRNA-na)-crRNA scaffold sequence-the second Second promoter-(gRNA-nb);

其中,n表示双gRNA的个数,n为≥1的整数。Wherein, n represents the number of double gRNAs, and n is an integer ≥ 1.

同一双gRNA文库中的双gRNA可以是仅针对一个靶基因设计的,也可以是针对多个靶基因设计的若干个双gRNA集的组合,一个双gRNA集针对一个靶基因。The double gRNA in the same double gRNA library can be designed for only one target gene, or it can be a combination of several double gRNA sets designed for multiple target genes, and one double gRNA set is aimed at one target gene.

本发明中,所述第一启动子和第二启动子为互不相同的聚合酶III启动子,如H1启动子或U6启动子。In the present invention, the first promoter and the second promoter are different polymerase III promoters, such as H1 promoter or U6 promoter.

本发明还提供了一种双gRNA载体文库,该载体文库由所述双gRNA文库与载体连接而成。本发明对载体无特殊要求,只要能够顺利转染细胞,使双gRNA能够在细胞内表达即可。The present invention also provides a double gRNA carrier library, which is formed by linking the double gRNA library with a carrier. The present invention has no special requirements on the carrier, as long as the cells can be successfully transfected so that the double gRNA can be expressed in the cells.

作为优选,所述载体上带有报告基因或抗性基因。报告基因或抗性基因有利于挑取靶基因被敲除的阳性克隆。Preferably, the carrier carries a reporter gene or a resistance gene. Reporter genes or resistance genes are useful for picking positive clones in which the target gene has been knocked out.

由于人工合成只能一次性获得长度大约为200nt的混合寡核苷酸,而本发明的双gRNA[第一启动子-(gRNA-a)-crRNA支架序列-第二启动子-(gRNA-b)]的总长度超过400nt,难以一次性合成获得。Since artificial synthesis can only obtain mixed oligonucleotides with a length of about 200nt at one time, the double gRNA of the present invention [the first promoter-(gRNA-a)-crRNA scaffold sequence-the second promoter-(gRNA-b )] has a total length of more than 400nt, which is difficult to synthesize at one time.

因此,本发明还提供了一种所述双gRNA载体文库的构建方法,该构建方法包括:Therefore, the present invention also provides a construction method of the double gRNA carrier library, the construction method comprising:

(1)针对一个双gRNA作用位点,合成序列结构为“PCR扩增短序列I-(gRNA-a)-间隔序列-(gRNA-b)-PCR扩增短序列II”的单链寡核苷酸,其中,间隔序列的两端均带有II类限制性内切酶的酶切位点;(1) Aiming at a dual gRNA action site, synthesize a single-stranded oligonucleotide with the sequence structure of "PCR amplified short sequence I-(gRNA-a)-spacer sequence-(gRNA-b)-PCR amplified short sequence II" Nucleotides, wherein both ends of the spacer sequence have restriction endonuclease cutting sites of type II;

其中,所述酶切位点可以是BsmB I、Sap I、BSA I;Wherein, the enzyme cutting site can be BsmB I, Sap I, BSA I;

所述PCR扩增短序列I的碱基序列为(如SEQ ID No.1所示):The base sequence of the PCR amplified short sequence I is (as shown in SEQ ID No.1):

5’-GTATGAGACCACTTGGATCC-3’;5'-GTATGAGACCACTTGGATCC-3';

所述PCR扩增短序列II的碱基序列为(如SEQ ID No.2所示):The base sequence of the PCR amplified short sequence II is (as shown in SEQ ID No.2):

5’-CCTTATTTTAACTTGCTATT-3’;5'-CCTTATTTTAACTTGCTATT-3';

将针对同一靶基因合成的所有单链寡核苷酸等量混合,或者,将针对所有靶基因合成的单链寡核苷酸等量混合,获得混合单链寡核苷酸库;Mix all single-stranded oligonucleotides synthesized for the same target gene in equal amounts, or mix equal amounts of single-stranded oligonucleotides synthesized for all target genes to obtain a mixed single-stranded oligonucleotide library;

上述混合单链寡核苷酸库可以由美国customarray公司通过“定制芯片”的方法合成;The above-mentioned mixed single-stranded oligonucleotide library can be synthesized by the US customarray company through the "custom chip" method;

(2)以步骤(1)中的混合单链寡核苷酸库为模板,利用相应的引物进行PCR扩增,获得混合双链寡核苷酸库;(2) Using the mixed single-stranded oligonucleotide library in step (1) as a template, using corresponding primers to perform PCR amplification to obtain a mixed double-stranded oligonucleotide library;

上下游引物分别与单链寡核苷酸中的PCR扩增短序列I和PCR扩增短序列II相结合,扩增获得混合双链寡核苷酸库;通过PCR扩增不仅可以获得双链寡核苷酸,以便后续连入载体中,而且能增加单链寡核苷酸的克隆数。The upstream and downstream primers are respectively combined with PCR amplified short sequence I and PCR amplified short sequence II in single-stranded oligonucleotides to amplify and obtain a mixed double-stranded oligonucleotide library; not only double-stranded oligonucleotides can be obtained by PCR amplification Oligonucleotides for subsequent ligation into the vector, and can increase the number of clones of single-stranded oligonucleotides.

(3)取经II类限制性内切酶线性化的载体,将步骤(2)中的混合双链寡核苷酸库连入该载体的第一启动子下游,获得前期文库;(3) Take the carrier linearized by class II restriction endonucleases, connect the mixed double-stranded oligonucleotide library in step (2) into the downstream of the first promoter of the carrier, and obtain the early stage library;

本步骤中的II类限制性内切酶可以与步骤(1)相同,也可以不同,只要该II类限制性内切酶能够在步骤(1)所述的酶切位点进行剪切即可。The class II restriction endonuclease in this step can be the same as step (1) or different, as long as the class II restriction endonuclease can cut at the enzyme cutting site described in step (1) .

本发明对第一启动子、第二启动子的来源均无要求,第一启动子可以是载体自身带有的,也可以是重组到载体上的外源性第一启动子。The present invention has no requirements on the source of the first promoter and the second promoter, and the first promoter may be carried by the vector itself, or may be an exogenous first promoter recombined into the vector.

(4)合成序列结构为“PCR扩增短序列I-crRNA支架序列-第二启动子-PCR扩增短序列II”的单链寡核苷酸库;(4) The synthetic sequence structure is a single-stranded oligonucleotide library of "PCR amplified short sequence I-crRNA scaffold sequence-the second promoter-PCR amplified short sequence II";

其中,所述crRNA支架序列的碱基序列为(如SEQ ID No.3所示):Wherein, the base sequence of the crRNA scaffold sequence is (as shown in SEQ ID No.3):

5’-GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCC-5'-GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCC-

-GTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCT-3’;-GTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCT-3';

本步骤中,PCR扩增短序列I和PCR扩增短序列II的碱基序列与步骤(1)中相同;In this step, the nucleotide sequences of the PCR amplified short sequence I and the PCR amplified short sequence II are the same as in step (1);

(5)以步骤(4)中的单链寡核苷酸库为模板,利用相应的引物进行PCR扩增,获得双链寡核苷酸库;(5) Using the single-stranded oligonucleotide library in step (4) as a template, using corresponding primers to perform PCR amplification to obtain a double-stranded oligonucleotide library;

(6)在II类限制性内切酶存在下,通过Gibson组装法将步骤(5)中的双链寡核苷酸库连入步骤(3)中的前期文库中,获得所述双gRNA载体文库。(6) In the presence of class II restriction endonucleases, connect the double-stranded oligonucleotide library in step (5) into the previous library in step (3) by Gibson assembly method to obtain the double gRNA vector library.

本步骤中的II类限制性内切酶可以与步骤(1)相同,也可以不同,只要该II类限制性内切酶能够在步骤(1)所述的酶切位点进行剪切即可。The class II restriction endonuclease in this step can be the same as step (1) or different, as long as the class II restriction endonuclease can cut at the enzyme cutting site described in step (1) .

II类限制性内切酶在前期文库中的间隔序列两端进行酶切,从而步骤(5)的双链寡核苷酸库能连入间隔序列所在位置,获得具有完整双gRNA序列结构的双gRNA载体文库。Class II restriction endonuclease cuts at both ends of the spacer sequence in the previous library, so that the double-stranded oligonucleotide library in step (5) can be connected to the position of the spacer sequence to obtain a double-stranded oligonucleotide with a complete double-gRNA sequence structure. gRNA vector library.

鉴于本发明的双gRNA对靶基因优异的靶向敲除性能,本发明还提供了所述双gRNA载体文库在基因敲除中的应用。In view of the excellent targeted knockout performance of the double gRNA of the present invention on target genes, the present invention also provides the application of the double gRNA carrier library in gene knockout.

并且,本发明的双gRNA载体文库尤其适用于lncRNA的敲除。Moreover, the double gRNA carrier library of the present invention is especially suitable for knocking out lncRNA.

对此,本发明提供了两种利用所述双gRNA载体文库敲除lncRNA的策略:In this regard, the present invention provides two strategies for knocking out lncRNA using the double gRNA carrier library:

①对于序列连贯的lncRNA,针对该lncRNA两端设计gRNA-a和gRNA-b,构建双gRNA载体文库,并利用该双gRNA载体文库转染或感染细胞,对细胞内的靶lncRNA进行敲除;① For lncRNAs with coherent sequences, design gRNA-a and gRNA-b for both ends of the lncRNA, construct a double gRNA carrier library, and use the double gRNA carrier library to transfect or infect cells to knock out the target lncRNA in the cells;

②对于序列中插入有其他基因或遗传元件的lncRNA,以该lncRNA中第一个外显子及其上游的启动子作为靶点,设计gRNA-a和gRNA-b,构建双gRNA载体文库,并利用该双gRNA载体文库转染或感染细胞,对细胞内的靶lncRNA进行敲除。②For the lncRNA with other genes or genetic elements inserted in the sequence, use the first exon in the lncRNA and its upstream promoter as the target, design gRNA-a and gRNA-b, construct a double gRNA vector library, and The cells are transfected or infected with the double gRNA vector library to knock out the target lncRNA in the cells.

本发明还提供了一种用于研究相应基因功能的基因敲除细胞文库,该基因敲除细胞文库是通过向稳定表达Cas9核酸酶的细胞中转染或感染所述双gRNA载体文库获得的。The present invention also provides a gene knockout cell library for studying corresponding gene functions, the gene knockout cell library is obtained by transfecting or infecting the double gRNA vector library into cells stably expressing Cas9 nuclease.

双gRNA载体文库转染或感染至稳定表达Cas9核酸酶的细胞内后,能够招募Cas9核酸酶将与双gRNA相对应的靶基因敲除,靶基因被敲除后的细胞表现型发生改变,从而可以用于确定靶基因功能。After the double gRNA carrier library is transfected or infected into cells stably expressing Cas9 nuclease, it can recruit Cas9 nuclease to knock out the target gene corresponding to the double gRNA, and the cell phenotype after the target gene is knocked out changes, thereby Can be used to determine target gene function.

与现有技术相比,本发明的有益效果为:Compared with prior art, the beneficial effect of the present invention is:

(1)与gRNA相比,本发明的双gRNA中,gRNA-a和gRNA-b分别由不同的启动子控制其独立表达,并分别与靶基因上的两个靶位点互补配对,这使得该双gRNA能够招募Cas9核酸酶在两个gRNA作用位点对靶基因进行剪切,对于蛋白编码基因敲除效率可达100%,而gRNA的敲除效率最高只能达到66.7%;(1) Compared with gRNA, in the double gRNA of the present invention, gRNA-a and gRNA-b are independently expressed by different promoters, and are complementary to two target sites on the target gene, which makes The double gRNA can recruit Cas9 nuclease to cut the target gene at the two gRNA action sites, and the knockout efficiency of protein-coding genes can reach 100%, while the knockout efficiency of gRNA can only reach 66.7%;

(2)与siRNA、shRNA相比,本发明的双gRNA可以回复实验,验证敲除基因的功能。(2) Compared with siRNA and shRNA, the double gRNA of the present invention can restore the experiment and verify the function of the knockout gene.

附图说明Description of drawings

图1为本发明双gRNA载体文库的构建流程图;Fig. 1 is the construction flowchart of double gRNA carrier library of the present invention;

其中,H1、U6分别表示H1、U6启动子,Lenti-hygro表示Lenti-hygro载体,Cut with BsmB I表示用限制性内切酶BsmB I对lenti-hygro载体进行剪切,Hygro表示潮霉素抗性基因,Scaffold表示支架,First step cloning表示第一步克隆,Spacer表示间隔序列,gRNA1、gRNA2分别表示一条sgRNA,Second step cloning表示第二步克隆,Lenti-dualgRNA-hygro-prelibrary表示前期文库,Lenti-dual gRNA-hygro-library表示双gRNAs载体文库;下同;Among them, H1 and U6 represent H1 and U6 promoters respectively, Lenti-hygro represents Lenti-hygro vector, Cut with BsmB I represents cutting lenti-hygro vector with restriction endonuclease BsmB I, Hygro represents hygromycin resistance Sex gene, Scaffold indicates the scaffold, First step cloning indicates the first step of cloning, Spacer indicates the spacer sequence, gRNA1 and gRNA2 respectively indicate a sgRNA, Second step cloning indicates the second step of cloning, Lenti-dualgRNA-hygro-prelibrary indicates the previous library, Lenti -dual gRNA-hygro-library means double gRNAs carrier library; the same below;

图2为双gRNA对lncRNA的敲除机制示意图;Figure 2 is a schematic diagram of the knockout mechanism of lncRNA by double gRNA;

其中,LncRNA表示长片段非编码RNA,gRNA-1、gRNA-2分别表示一条sgRNA,flanking表示侧翼(序列或区域),1st exon表示第一个外显子,Last exon表示最后一个外显子,Myc表示Myc基因,hCas9表示人类密码子优化的Cas9核酸酶基因,NLS表示核定位信号,deleted表示原LncRNA已被双gRNA敲除;下同;Among them, LncRNA represents a long non-coding RNA, gRNA-1 and gRNA-2 represent a sgRNA respectively, flanking represents a flank (sequence or region), 1 st exon represents the first exon, and Last exon represents the last exon , Myc means Myc gene, hCas9 means human codon-optimized Cas9 nuclease gene, NLS means nuclear localization signal, deleted means that the original LncRNA has been knocked out by double gRNA; the same below;

图3为sgRNA和双gRNA的基因敲除效率比较结果;Figure 3 is the comparison result of gene knockout efficiency of sgRNA and double gRNA;

其中,Single gRNA表示单条sgRNA,Dual gRNA表示两条sgRNA即双gRNA,EF1表示启动子,E1、E2、E3分别表示UCA1基因的三个外显子,Marker表示DNA分子量标准,Vector表示载体,UCA1KO(2、4、14、16、19)表示UCA1基因被Single gRNA敲除的克隆(克隆编号为2、4、14、16、19),UCA1KO(3、5、12、17)表示UCA1基因被Dual gRNA敲除的克隆(克隆编号为3、5、12、17),Genomic PCR表示基因组DNA的PCR结果;下同;Among them, Single gRNA means a single sgRNA, Dual gRNA means two sgRNAs (double gRNA), EF1 means promoter, E1, E2, E3 means three exons of UCA1 gene, Marker means DNA molecular weight standard, Vector means carrier, UCA1KO (2, 4, 14, 16, 19) indicate clones in which the UCA1 gene was knocked out by Single gRNA (clone numbers are 2, 4, 14, 16, 19), and UCA1KO (3, 5, 12, 17) indicate that the UCA1 gene was knocked out Dual gRNA knockout clones (clone numbers are 3, 5, 12, 17), Genomic PCR indicates the PCR results of genomic DNA; the same below;

图4为不同敲除策略下双gRNA对长lncRNA的敲除效率比较结果;Figure 4 is the comparison result of the knockout efficiency of double gRNA to long lncRNA under different knockout strategies;

其中,chr8表示8号染色体,1~8表示PTV1基因上的八个外显子、且第3~5个外显子分别是miR-1205,1206,1207,Exon 1、Exon 8表示第1、8个外显子,E1KO表示PTV1基因第1个外显子被敲除的克隆,E1+P KO表示PTV1基因第1个外显子及其上游启动子区域被敲除的克隆,RelativePVT1level(%)表示PTV1基因的相对表达水平(%);Among them, chr8 represents chromosome 8, 1-8 represent the eight exons on the PTV1 gene, and the 3rd to 5th exons are miR-1205, 1206, 1207 respectively, Exon 1 and Exon 8 represent the first, 8 exons, E1KO means the clone with the first exon of PTV1 gene knocked out, E1+P KO means the clone with the first exon of PTV1 gene and its upstream promoter region knocked out, RelativePVT1level(% ) represents the relative expression level (%) of PTV1 gene;

图5为双gRNA对AK023948基因的敲除效果图;Figure 5 is a diagram of the knockout effect of the double gRNA on the AK023948 gene;

其中,AK023948KO(#13、#28、#32)表示AK023948基因被敲除的克隆(克隆编号为#13、#28、#32),Relative AK0level(%)表示AK023948基因的相对表达水平(%)。Among them, AK023948KO (#13, #28, #32) means the clones with AK023948 gene knocked out (clone numbers are #13, #28, #32), and Relative AK0level (%) means the relative expression level (%) of AK023948 gene .

具体实施方式detailed description

下面结合附图和具体实施方式对本发明的技术方案作进一步详细说明。The technical solution of the present invention will be described in further detail below in conjunction with the accompanying drawings and specific embodiments.

实施例1双gRNA载体文库的构建The construction of embodiment 1 double gRNA carrier library

在非编码数据库(www.http://noncode.org/)中列出的lncRNA超过50000,原则上本发明双gRNA载体文库的构建没有数量上限,但考虑到当前美国customarray公司通过“定制芯片”的方法合成单链寡核苷酸的数量上限,我们从中筛选除了大约45000条可以适用于sgRNA标记的lncRNA,为每个lncRNA设计了两个双gRNA,以构成总数为9000的双gRNA KO文库。此外,还设置了100个非人类基因阴性对照双gRNA。There are more than 50,000 lncRNAs listed in the non-coding database (www.http://noncode.org/). In principle, there is no upper limit for the construction of the double gRNA carrier library of the present invention, but considering that the current U.S. customarray company uses "custom chips" The upper limit of the number of single-stranded oligonucleotides synthesized by the method, we screened about 45,000 lncRNAs suitable for sgRNA labeling, and designed two double gRNAs for each lncRNA to constitute a total of 9,000 double gRNA KO libraries. In addition, 100 non-human gene negative control double gRNAs were also set up.

本实施例双gRNA KO文库的构建方法(构建流程如图1所示)包括:The construction method of the double gRNA KO library in this embodiment (the construction process is shown in Figure 1) includes:

(1)制备混合单链寡核苷酸库(1) Preparation of mixed single-stranded oligonucleotide library

委托美国customarray公司(http://www.customarrayinc.com/)通过“定制芯片”的方法合成相应的单链寡核苷酸,获得混合单链寡核苷酸库;Entrust the American customarray company (http://www.customarrayinc.com/) to synthesize the corresponding single-stranded oligonucleotides through the "custom chip" method to obtain a mixed single-stranded oligonucleotide library;

(2)制备混合双链寡核苷酸库(2) Preparation of mixed double-stranded oligonucleotide library

以混合单链寡核苷酸库为模板,利用引物进行PCR扩增:Use the mixed single-stranded oligonucleotide library as a template, and use primers for PCR amplification:

在1mL管中依次加入:5×PCR反应缓冲液80μL、dNTP混合物(10mM)8μL,Phusion聚合酶(2U/μL)2μL,H1-5.1引物(10μM)10μL,Scaffold-adaptor引物(10μM)10μL,模板(80ng/μL)2μL,加去离子水至总体积为400μL。In a 1mL tube, add: 80μL of 5×PCR reaction buffer, 8μL of dNTP mixture (10mM), 2μL of Phusion polymerase (2U/μL), 10μL of H1-5.1 primer (10μM), 10μL of Scaffold-adaptor primer (10μM), Template (80ng/μL) 2μL, add deionized water to a total volume of 400μL.

其中,H1-5.1引物(如SEQ ID No.4所示)即结合在前文所述“PCR扩增短序列I”位置处,Scaffold-adaptor引物(如SEQ ID No.5所示)即结合在前文所述“PCR扩增短序列II”位置处。两者的碱基序列分别为:Wherein, the H1-5.1 primer (as shown in SEQ ID No.4) is combined at the position of "PCR amplified short sequence I" described above, and the Scaffold-adaptor primer (as shown in SEQ ID No.5) is combined at At the position of "PCR amplified short sequence II" mentioned above. The base sequences of the two are:

H1-5.1引物:5’-GTATGAGACCACTTGGATCC-3’;H1-5.1 primer: 5'-GTATGAGACCACTTGGATCC-3';

Scaffold-adaptor引物:5’-CCTTATTTTAACTTGCTATT-3’。Scaffold-adaptor primer: 5'-CCTTATTTTAACTTGCTATT-3'.

将PCR反应体系混匀后稍离心,分装至8个PCR管中(50μl/tube),在PCR仪中进行扩增反应,反应参数为:98℃1min,1个循环,98℃0.5min,42℃1min,72℃0.5min,循环33个,72℃4min,1个循环,4℃保存。Mix the PCR reaction system evenly, centrifuge it slightly, divide it into 8 PCR tubes (50μl/tube), and carry out the amplification reaction in a PCR instrument. The reaction parameters are: 98°C for 1min, 1 cycle, 98°C for 0.5min, 42°C 1min, 72°C 0.5min, 33 cycles, 72°C 4min, 1 cycle, 4°C storage.

采用美国Zymo Research公司纯化试剂盒对PCR产物进行纯化:The PCR product was purified using the Zymo Research Purification Kit of the United States:

对于每200μL PCR溶液,加入1mL连接缓冲液,转移到纯化柱中,离心机(Eppendoff)15,000rpm离心0.5min。丢弃离心液,加200μL washbuffer,15,000rpm离心0.5min;加200μL wash buffer,15,000rpm离心1min,将离心柱转移至一个新管中,加40μL水至柱中,15,000rpm离心1min,保存洗脱液(即为混合双链寡核苷酸库),用于后续第一步克隆。For every 200 μL of PCR solution, 1 mL of ligation buffer was added, transferred to a purification column, and centrifuged in a centrifuge (Eppendoff) at 15,000 rpm for 0.5 min. Discard the centrifugate, add 200μL wash buffer, centrifuge at 15,000rpm for 0.5min; add 200μL wash buffer, centrifuge at 15,000rpm for 1min, transfer the spin column to a new tube, add 40μL water to the column, centrifuge at 15,000rpm for 1min, save the eluate (that is, a mixed double-stranded oligonucleotide library) for the subsequent first step of cloning.

(3)载体的制备(3) Preparation of carrier

用BsmB I(美国NEB公司)消化lenti-hygro载体。消化体系为:Buffer3.1 10μL,lenti-hygro载体2μg,BsmB I(10units/μL)2μL,加水至100μL,55℃消化3小时。The lenti-hygro vector was digested with BsmBI (NEB, USA). The digestion system is: Buffer3.1 10 μL, lenti-hygro carrier 2 μg, BsmB I (10 units/μL) 2 μL, add water to 100 μL, digest at 55°C for 3 hours.

1%琼脂糖凝胶,80恒定电流30min,分离消化后的DNA(用美国Zymo Research公司DNA割胶回收试剂盒),切割线性DNA条带,在1.5mL管中,加入溶胶液(Zymo Research),每100μg胶加300μL溶胶液,55℃约5min、或者直至胶全部溶解。转移至纯化柱,离心机(Eppendoff)15,000rpm离心0.5min,加200μL wash buffer,15,000rpm离心0.5min;加200μL wash buffer,15,000rpm离心1min;将离心柱转移至一个新管中,加40μL水至柱中,15,000rpm离心1min,保存洗脱液,用于第一步克隆。1% agarose gel, 80 constant current for 30min, separate the digested DNA (using DNA tapping recovery kit from Zymo Research, USA), cut the linear DNA band, add sol solution (Zymo Research) to a 1.5mL tube, Add 300 μL of colloidal solution per 100 μg of gelatin, at 55°C for about 5 minutes, or until the gelatin is completely dissolved. Transfer to the purification column, centrifuge (Eppendoff) at 15,000rpm for 0.5min, add 200μL wash buffer, centrifuge at 15,000rpm for 0.5min; add 200μL wash buffer, centrifuge at 15,000rpm for 1min; transfer the spin column to a new tube, add 40μL water Put it into the column, centrifuge at 15,000rpm for 1min, and save the eluate for the first step of cloning.

(4)第一步克隆(制备前期文库)(4) The first step of cloning (preparation of pre-library)

在管中加入4μL PCR产物(即混合双链寡核苷酸库),4μL lenti-hygro载体/BsmB1,2μL cold fusion(SBI),室温下静置混合5min,转移到冰上静置10min后加入50μL感受态细胞(10G购自美国Lucigen公司),在冰上放30min,42℃水浴1min,再转移到冰上静置2~5min,加500μLLB培养基,于37℃、250rpm下震荡培养60min,取250μL平铺在氨苄青霉素(100μg/mL)LB平板上,在37℃下孵育过夜,第二天计克隆数。Add 4 μL of PCR product (i.e. mixed double-stranded oligonucleotide library), 4 μL of lenti-hygro carrier/BsmB1, 2 μL of cold fusion (SBI) into the tube, let it stand at room temperature for 5 minutes, transfer to ice and let it stand for 10 minutes before adding 50 μL of competent cells (10G purchased from Lucigen, USA) were placed on ice for 30 min, then placed in a water bath at 42°C for 1 min, then transferred to ice and allowed to stand for 2–5 min, then added with 500 μL of LB medium, and cultured with shaking at 37°C and 250 rpm for 60 min. Take 250 μL and spread it on an ampicillin (100 μg/mL) LB plate, incubate overnight at 37°C, and count the number of clones the next day.

根据文库的大小,我们需要5~10倍的覆盖范围,即10000个双gRNA库,我们需要50,000到100,000的克隆。Depending on the size of the library, we need 5-10x coverage, that is, for 10,000 double-gRNA libraries, we need 50,000 to 100,000 clones.

用美国的Zymo Research公司的质粒提取试剂盒分离含有双gRNA表达载体的转化细菌中的质粒,提取步骤为:Use the plasmid extraction kit of Zymo Research Company in the United States to isolate the plasmid in the transformed bacteria containing the double gRNA expression vector. The extraction steps are:

前期文库DNA 2μg,10x buffer 3.1(美国NEB公司)10μL,BsmB I(10units/μL)2μL,加水至100μL,55℃消化3小时。Pre-library DNA 2μg, 10x buffer 3.1 (NEB, USA) 10μL, BsmB I (10units/μL) 2μL, add water to 100μL, digest at 55°C for 3 hours.

1%琼脂糖凝胶,80恒定电流30min,分离消化后的DNA(用美国Zymo Research公司DNA割胶回收试剂盒),切割线性DNA条带,在1.5mL管中,加入溶胶液((Zymo Research),每100μg胶加300μL溶胶液,55℃约5mins或者至胶全部溶解。转移至纯化柱,离心机(Eppendoff)15,000rpm离心0.5min,加200μL wash buffer,15,000rpm离心0.5min;加200μL wash buffer,15,000rpm离心1min;将离心柱转移至一个新管中,加40μL水至柱中,15,000rpm离心1min,保存洗脱液(质粒DNA,即前期文库)用于第二步克隆。1% agarose gel, 80 constant current for 30min, separate the digested DNA (using the U.S. Zymo Research company DNA tapping gel recovery kit), cut the linear DNA band, in a 1.5mL tube, add the sol solution ((Zymo Research) , add 300μL sol solution for every 100μg gel, 55℃ for about 5mins or until the gel is completely dissolved. Transfer to the purification column, centrifuge (Eppendoff) at 15,000rpm for 0.5min, add 200μL wash buffer, centrifuge at 15,000rpm for 0.5min; add 200μL wash buffer , Centrifuge at 15,000rpm for 1min; transfer the spin column to a new tube, add 40μL of water to the column, centrifuge at 15,000rpm for 1min, and save the eluate (plasmid DNA, that is, the previous library) for the second step of cloning.

(5)Scaffold-U6片段的制备(5) Preparation of Scaffold-U6 fragment

在管中依次加入5×PCR反应缓冲液80μL,支架-U6的上游引物(Scaffold-U6-5.1:5’-GTTTTAGAGCTAGAAAT-3’)(如SEQ ID No.6所示)和下游引物(Scaffold-U6-3.1:5’-ACGGTGTTTCGTCCTTTC-3’)(如SEQ ID No.7所示)各10μL(10μM),dNTP混合物(10mM)8μL,带有Scaffold-U6的质粒(100ng/μL)1μL(委托美国genscript公司合成),Phusion聚合酶(2U/μL)2μL,加去离子水至总体积为400μL。混匀后稍离心分装分装至8个PCR管中,每个管50μL,在PCR仪中进行扩增反应,PCR反应参数为:98℃1min,1个循环,98℃0.5min,42℃1min,72℃0.5min,循环33个,72℃4min,1个循环,4℃保存,备用。Add 80 μL of 5×PCR reaction buffer, scaffold-U6 upstream primer (Scaffold-U6-5.1: 5'-GTTTTAGGCTAGAAAT-3') (as shown in SEQ ID No.6) and downstream primer (Scaffold- U6-3.1: 5'-ACGGTGTTTCGTCCTTTC-3') (shown in SEQ ID No.7) 10 μL (10 μM), dNTP mixture (10 mM) 8 μL, plasmid with Scaffold-U6 (100 ng/μL) 1 μL (entrusted Synthesized by American genscript company), Phusion polymerase (2U/μL) 2 μL, add deionized water to a total volume of 400 μL. After mixing, centrifuge slightly and divide into 8 PCR tubes, each tube is 50 μL, and carry out the amplification reaction in a PCR instrument. The PCR reaction parameters are: 98°C for 1min, 1 cycle, 98°C for 0.5min, 42°C 1min, 0.5min at 72°C, 33 cycles, 4min at 72°C, 1 cycle, store at 4°C for later use.

(6)第二步克隆(6) The second step of cloning

在管中加入4μL PCR产物(Scaffold-U6片段),4μL用BsmB I酶切的前期文库,2μL cold fusion(SBI),室温下静置5min后转移到冰上静置10min;加入50μL感受态细胞(10G购置美国Lucigen公司),在冰上放30min后42℃下水浴1min,再转移到冰上静置2~5min,加入500μL LB培养液,于37℃、250rpm下震荡培养60min,取250μL培养液平铺在氨苄青霉素(100μg/mL)LB平板上,在37℃孵育过夜,第二天数克隆数。Add 4 μL of PCR product (Scaffold-U6 fragment), 4 μL of pre-digested library with BsmB I, 2 μL of cold fusion (SBI), let stand at room temperature for 5 minutes, then transfer to ice for 10 minutes; add 50 μL of competent cells (10G was purchased from American Lucigen Company), put it on ice for 30 minutes, then put it in a water bath at 42°C for 1 minute, then transferred it to ice and let it stand for 2-5 minutes, then added 500 μL of LB culture medium, cultured with shaking at 37°C and 250 rpm for 60 minutes, and took 250 μL of culture medium The solution was plated on ampicillin (100 μg/mL) LB plates, incubated overnight at 37°C, and the number of clones was counted the next day.

根据文库的大小,我们需要5~10倍的覆盖范围,即10000个双gRNA库,我们需要50,000到100,000的克隆。Depending on the size of the library, we need 5-10x coverage, that is, for 10,000 double-gRNA libraries, we need 50,000 to 100,000 clones.

用美国的Zymo Research公司的质粒提取试剂盒分离含有双gRNA表达载体的转化细菌中的质粒(即双gRNA载体文库),纯化保存,用于后续包病毒用。Use the plasmid extraction kit of Zymo Research Company in the United States to isolate the plasmid in the transformed bacteria containing the double gRNA expression vector (ie, the double gRNA vector library), purify and store it, and use it for subsequent viral packaging.

双gRNA载体文库可以用于筛选在基因调控与疾病进程中发挥显著作用的必需基因,也可以用于鉴定必不可少的编码基因或者其他遗传元件的功能。The double gRNA vector library can be used to screen essential genes that play a significant role in gene regulation and disease progression, and can also be used to identify the functions of essential coding genes or other genetic elements.

双gRNA对LncRNA的敲除机制如图2所示。The knockout mechanism of double gRNA to LncRNA is shown in Figure 2.

实施例3single gRNA和双gRNA的基因敲除效率比较The gene knockout efficiency comparison of embodiment 3 single gRNA and double gRNA

本实施例以带有3个外显子的UCA1基因为例,比较sgRNA和双gRNA的基因敲除效率(如图3)。In this example, the UCA1 gene with 3 exons is taken as an example to compare the gene knockout efficiency of sgRNA and double gRNA (as shown in Figure 3).

(1)双gRNA的基因敲除效率(1) Gene knockout efficiency of double gRNA

以UCA1基因作为靶基因,在靶基因上选择靶位点(如图3中D部分所示),设计UCA1-dual gRNA,UCA1-dual gRNA中两条gRNA的正义链的碱基序列分别为:Using the UCA1 gene as the target gene, select the target site on the target gene (as shown in part D in Figure 3), and design UCA1-dual gRNA, the base sequences of the sense strands of the two gRNAs in the UCA1-dual gRNA are respectively:

UCA1-gRNA1(SEQ ID No.8):5’-GTGCATGGTGGAGAGATGAT-3’;UCA1-gRNA1 (SEQ ID No.8): 5'-GTGCATGGTGGAGAGATGAT-3';

UCA1-gRNA2(SEQ ID No.9):5’-TTCTGGAATGGTGAACCCAA-3’;UCA1-gRNA2 (SEQ ID No.9): 5'-TTCTGGAATGGTGAACCCAA-3';

委托美国genscript公司构建含有hCas9和UCA1-dual gRNA的表达载体(每个DNA含量均为0.5μg),并利用该表达载体对293T细胞进行转染敲除,敲除步骤如下:Entrust the American genscript company to construct the expression vector containing hCas9 and UCA1-dual gRNA (each DNA content is 0.5 μg), and use the expression vector to transfect and knock out 293T cells. The knockout steps are as follows:

1)传代293T细胞,并保持细胞密度大约30%,37℃过夜;1) Subculture 293T cells, and maintain the cell density at about 30%, overnight at 37°C;

2)含hCas9和UCA1-dual gRNA的表达载体(如图3中B部分所示)在6孔板中用转染试剂如DNAfectin(美国ABM公司)或者lipofectin(美国Thermo Fisher公司)转染细胞;2) The expression vector containing hCas9 and UCA1-dual gRNA (as shown in part B in FIG. 3 ) is used in a 6-well plate to transfect cells with a transfection reagent such as DNAfectin (ABM Company, USA) or lipofectin (Thermo Fisher Company, USA);

3)转染后6小时换血清培养基;3) Change the serum medium 6 hours after transfection;

4)第二天,通过FACS细胞分选仪分离单个细胞;4) The next day, separate single cells by FACS cell sorter;

5)在96孔板中让单个细胞生长10日左右;5) Let a single cell grow for about 10 days in a 96-well plate;

6)转移克隆到24孔板生长5天以上;6) Transfer clones to a 24-well plate and grow for more than 5 days;

7)用美国Viagen Biotech公司试剂盒分离UCA1敲除克隆的基因组DNA:7) Genomic DNA of UCA1 knockout clones was isolated with a kit from Viagen Biotech, USA:

a)在10cm平板细胞加200-300μL DirectPCR裂解试剂(Cell),同时加新鲜配制0.2~0.4mg/mL的蛋白酶K(Sigma);55℃水浴旋转管1小时,或观察直到无团块;85℃水浴裂解45分钟。离心10秒,-20℃保存;a) Add 200-300 μL of DirectPCR Lysis Reagent (Cell) to the cells on a 10 cm plate, and add freshly prepared 0.2-0.4 mg/mL proteinase K (Sigma) at the same time; rotate the tube in a water bath at 55°C for 1 hour, or observe until there are no lumps; 85 Cleavage in a water bath for 45 minutes. Centrifuge for 10 seconds and store at -20°C;

b)取0.5μl裂解液作为模板,进行PCR反应,反应体系包含:10×PCR反应缓冲液1μL,上游引物(UCA1-inside-5.3:5’-CCTTAACTAATTAAC--CCACC-3’)(如SEQ ID No.10所示)和下游引物(UCA1-inside-3.3:5’-AAGAGAGTCAGCGAAGGGAG-3’)(如SEQ ID No.11所示)各0.5μL(10μM),dNTP混合物(10mM)0.2μL,DMSO 0.3μL,Taq聚合酶(美国NEB公司)(2U/μL)0.2μL,加去离子水6.8μL至总体积为10μL;b) Take 0.5 μl of the lysate as a template for PCR reaction, the reaction system includes: 1 μL of 10×PCR reaction buffer, upstream primer (UCA1-inside-5.3: 5'-CCTTAACTAATTAAC--CCACC-3') (such as SEQ ID No.10) and downstream primer (UCA1-inside-3.3: 5'-AAGAGAGTCAGCGAAGGGAG-3') (as shown in SEQ ID No.11) each 0.5μL (10μM), dNTP mixture (10mM) 0.2μL, DMSO 0.3 μL, Taq polymerase (NEB, USA) (2U/μL) 0.2 μL, add 6.8 μL of deionized water to a total volume of 10 μL;

c)在PCR仪中进行DNA扩增反应,PCR反应参数为:94℃1min,1个循环,94℃0.5min,55℃0.5min,72℃0.5min,循环33个,72℃10min,1个循环,4℃保存;c) Carry out DNA amplification reaction in a PCR instrument. The PCR reaction parameters are: 94°C 1min, 1 cycle, 94°C 0.5min, 55°C 0.5min, 72°C 0.5min, 33 cycles, 72°C 10min, 1 cycle Cycle, store at 4°C;

d)反应结束后取4μL反应液,进行1%琼脂糖凝胶电泳检测UCA1的缺失状况(如图3中F部分所示)。d) After the reaction, 4 μL of the reaction solution was taken and subjected to 1% agarose gel electrophoresis to detect the absence of UCA1 (as shown in part F in FIG. 3 ).

(2)single gRNA的基因敲除效率(2) Gene knockout efficiency of single gRNA

以UCA1基因作为靶基因,在靶基因上选择靶位点(如图3中C部分所示),设计UCA1-gRNA,UCA1-gRNA与上述UCA1-gRNA1相同。Using the UCA1 gene as the target gene, select the target site on the target gene (as shown in part C in FIG. 3 ), and design UCA1-gRNA, which is the same as the UCA1-gRNA1 above.

采用与本实施例第(1)部分相同的方法构建含hCas9和UCA1-gRNA的表达载体(如图3中A部分所示),利用该表达载体转染目标细胞,分离UCA1敲除克隆的总RNA进行RT-PCR,检测UCA1的表达量(如图3中E部分所示)。The expression vector containing hCas9 and UCA1-gRNA (as shown in part A in Figure 3) was constructed using the same method as in part (1) of this example, and the expression vector was used to transfect target cells, and the total cells of UCA1 knockout clones were isolated. The RNA was subjected to RT-PCR to detect the expression level of UCA1 (as shown in part E in FIG. 3 ).

RT-PCR的步骤为:The steps of RT-PCR are:

a)RNA的提取:用Direcozol TM RNA MIN/prep试剂盒提取293T细胞中的RNA,24孔每孔加500μl(trl reagent)(cat.R2050-100)样品需放冰上;a) Extraction of RNA: Extract RNA from 293T cells with Direcozol TM RNA MIN/prep kit, add 500 μl (trl reagent) (cat.R2050-100) to each well of 24 wells and place the sample on ice;

b)冰冻样品需用枪头混合,加入等量的95%乙醇混匀;b) Frozen samples need to be mixed with a pipette tip, and an equal amount of 95% ethanol is added to mix well;

c)将混合液移入专用(Zymo-spin)IIC柱子,13500rpm离心1min,将离心柱换到新的收集管;c) Transfer the mixed solution into a special (Zymo-spin) IIC column, centrifuge at 13500rpm for 1min, and replace the spin column with a new collection tube;

d)加400μl Direcozol TM RNA prewash到(Zymo-spin)IIC柱子,.13500rpm离心1min;d) Add 400μl Direcozol TM RNA prewash to the (Zymo-spin) IIC column, and centrifuge at 13500rpm for 1min;

e)重复步骤d);e) repeat step d);

f)加700μl RNA wash buffer到(Zymo-spin)IIC柱子,13500rpm离心1min。丢去离心液,13500rpm空离心2min;f) Add 700 μl RNA wash buffer to the (Zymo-spin) IIC column, and centrifuge at 13500 rpm for 1 min. Throw away the centrifugate and centrifuge at 13500rpm for 2min;

g)加25μl Dnease/RNAease free water到(Zymo-spin)IIC离心柱,13500rpm空离心1min;g) Add 25μl Dnease/RNAease free water to (Zymo-spin) IIC spin column, and centrifuge at 13500rpm for 1min;

h)利用核酸仪Nano drop2000C测RNA浓度(美国Thermo Scientific公司);h) Utilize nucleic acid instrument Nano drop2000C to measure RNA concentration (Thermo Scientific Company of the United States);

i)逆转录:所用试剂均放冰上,逆转录体系:RNA 0.5μg,随机引物(randomprimer mix#s1330s)0.5μl,DEPC H2O加至7μl,PCR仪70℃10minutes后放冰上;i) Reverse transcription: put all reagents on ice, reverse transcription system: 0.5 μg RNA, 0.5 μl random primer (randomprimer mix#s1330s), add DEPC H 2 O to 7 μl, put the PCR instrument on ice at 70°C for 10 minutes;

j)RT-每个样本加以下:Thermo scicentiitic 5X first stand buffer(lot00168122)2μl,dNTP(signa deoxynuclrotide mix,lot susf-45360us)0.5μl,Rnase inhibitor(munne#Mo314l)(lot10081460)0.25μl Revert AidRT(revertaid.lt 00205481)reverse T anscrripatse#epo441 0.25μl,混匀,反应参数设置为25℃10min,37℃1hour,70℃10min(eppendorf orBIO-RAD T100thermal cycler),得到模板cDNA;j) RT- add the following to each sample: Thermo scicentiitic 5X first stand buffer (lot00168122) 2μl, dNTP (signa deoxynuclrotide mix, lot susf-45360us) 0.5μl, Rnase inhibitor (munne#Mo314l) (lot10081460) 0.25μl Revert AidRT ( revertaid.lt 00205481) reverse Tanscrripatse#epo441 0.25μl, mix well, set the reaction parameters as 25°C for 10min, 37°C for 1hour, 70°C for 10min (eppendorf orBIO-RAD T100thermal cycler) to obtain template cDNA;

k)QPCR:在新的0.2mL PCR反应管中依次加入10μL real-time PCRMaster Mix,0.4μL 50×ROX reference,相应的PCR正向和反向引物(10μM)各0.4μL,2μL模板cDNA(上面逆转录步骤所得)和6.8μL去离子水;混匀后进行PCR反应,反应条件为:95℃3min,循环条件为95℃10s和60℃0.5min,65℃0.05s,共39个循环,每个样本重复3次,通过该反应可得UCA1基因敲除后的表达量。k) QPCR: Add 10 μL real-time PCRMaster Mix, 0.4 μL 50×ROX reference, 0.4 μL each of the corresponding PCR forward and reverse primers (10 μM), and 2 μL template cDNA (above obtained from the reverse transcription step) and 6.8 μL of deionized water; after mixing, PCR reaction was carried out. The reaction conditions were: 95°C for 3min, the cycle conditions were 95°C for 10s and 60°C for 0.5min, 65°C for 0.05s, a total of 39 cycles, each Each sample was repeated 3 times, and the expression level after UCA1 gene knockout could be obtained through this reaction.

由图3可见,在随机选取的UCA1敲除克隆中,经UCA1-gRNA敲除的UCA1敲除克隆中还含有UCA1基因,而经UCA1-dual gRNA敲除的UCA1敲除克隆中则检测不到UCA1基因,表明双gRNA比sgRNA具有更高的敲除效率。It can be seen from Figure 3 that in the randomly selected UCA1 knockout clones, the UCA1 knockout clones knocked out by UCA1-gRNA also contained the UCA1 gene, while the UCA1 knockout clones knocked out by UCA1-dual gRNA could not be detected UCA1 gene, indicating that double gRNA has a higher knockdown efficiency than sgRNA.

实施例3双gRNA对长lncRNA的敲除策略Example 3 The knockout strategy of double gRNA to long lncRNA

当lncRNA基因太长时,一些其他的基因如microRNA将插入到其中。比如PVT1基因有8个外显子,而且其基因区间长度超过200kb(chr8:128,902,874-129,113,499),三个microRNAs(miR-1205~1207)都位于这段区域内(如图4中A部分)。如果采用与实施例3相同的敲除策略将这段超过200kb区域全部剪切掉,可能也会将这三个microRNAs以及其他一些潜在的基因或者基因元件同时删减掉,这将导致我们无法明确地判断剪切后的表现型到底是跟PVT1有关还是跟其他因素有关。When the lncRNA gene is too long, some other genes such as microRNA will be inserted into it. For example, the PVT1 gene has 8 exons, and its gene interval is more than 200kb (chr8:128,902,874-129,113,499), and three microRNAs (miR-1205-1207) are located in this region (part A in Figure 4). If the same knockout strategy as in Example 3 is used to cut out all the regions exceeding 200kb, these three microRNAs and some other potential genes or genetic elements may also be deleted at the same time, which will make it impossible for us to determine It is necessary to accurately judge whether the cut phenotype is related to PVT1 or other factors.

因此,针对PVT1基因设计了两种敲除策略:Therefore, two knockout strategies were designed for the PVT1 gene:

(1)采用与实施例3相同的方法设计用于剪切PVT1基因第一个外显子的双gRNA(如图4中B部分);(1) Using the same method as in Example 3 to design a double gRNA for cutting the first exon of the PVT1 gene (as shown in Part B in Figure 4);

(2)采用与实施例3相同的方法设计用于剪切PVT1基因第一个外显子以及第一个外显子转录上游1.1kb区域的双gRNA(如图4中C部分);(2) Using the same method as in Example 3 to design a double gRNA for cutting the first exon of the PVT1 gene and the 1.1kb region upstream of the transcription of the first exon (as shown in part C in Figure 4);

采用与实施例3第(1)部分相同的方法,分别构建含hCas9和PVT1-dual gRNA(gRNA1-gRNA2)的表达载体、含hCas9和PVT1-dualgRNA(gRNA1p-gRNA2)的表达载体,并分别利用这两种表达载体转染目标细胞,分离KO克隆的基因组DNA进行PCR,检测KO克隆中PVT1基因的缺失情况(如图4中C、D部分所示)。Using the same method as in Example 3 (1), the expression vectors containing hCas9 and PVT1-dual gRNA (gRNA1-gRNA2) and the expression vectors containing hCas9 and PVT1-dual gRNA (gRNA1p-gRNA2) were respectively constructed, and used respectively The two expression vectors were transfected into the target cells, and the genomic DNA of the KO clone was isolated for PCR to detect the deletion of the PVT1 gene in the KO clone (as shown in parts C and D in FIG. 4 ).

由图4可见,第一种敲除策略虽然将PVT1基因的第一个外显子敲除了,但PVT1基因的其他外显子仍旧表达。而第二种敲除策略将PVT1基因的第一个外显子以及第一个外显子转录上游1.1kb区域敲除了之后,则没有检测到外显子1和外显子8的表达。It can be seen from FIG. 4 that although the first knockout strategy knocks out the first exon of the PVT1 gene, other exons of the PVT1 gene are still expressed. However, after the second knockout strategy knocked out the first exon of PVT1 gene and the 1.1 kb region upstream of the transcription of the first exon, the expression of exon 1 and exon 8 was not detected.

这是因为与蛋白质编码基因类似,绝大多数lncRNA是通过RNA聚合酶II转录的。虽然启动子可能包含一个非常大的区域,但是一些增强区域和基本转录元件都是位于转录上游500bp区间之内的。为了保险起见,我们设计了带有从1KB~转录上游的sgRNA1p。例如,PVT1的gRNA1p在1.1kb区域而gRNA2位于第一个外显子底端,总共包含了长达1.5kb区域。从而含有gRNA1p-gRNA2的双gRNA能够完成对PVT1整个转录的敲除。This is because, similar to protein-coding genes, the vast majority of lncRNAs are transcribed by RNA polymerase II. Although a promoter may contain a very large region, several enhancer regions and basic transcriptional elements are located within 500 bp upstream of transcription. To be on the safe side, we designed sgRNA1p with transcription upstream from 1KB. For example, gRNA1p of PVT1 is located in the 1.1 kb region and gRNA2 is located at the bottom of the first exon, covering a total of up to 1.5 kb. Thus, the double gRNA containing gRNA1p-gRNA2 can complete the knockout of the entire transcription of PVT1.

另外,含有gRNA1p-gRNA2的双gRNA对于miR-2015~miR-2017没有任何影响,显示了它们可能有相应的启动子。In addition, the double gRNA containing gRNA1p-gRNA2 had no effect on miR-2015~miR-2017, indicating that they may have corresponding promoters.

实施例4双gRNA KO文库的应用Example 4 Application of double gRNA KO library

虽然在各种生理和病理条件下已经越来越多地认识到长非编码RNA(lncRNA)的作用,但是大量lncRNA在乳腺癌的潜在作用还鲜为人知。我们通过RT-PCR研究了lncRNA的表达谱,确定了一组分别为相对于正常乳腺组织中的患者乳腺癌组织差异表达的lncRNA。其中,AK023948在乳腺癌中上调,同时在乳腺癌细胞系(MCF-7和MDA-MB-231)中相比于人乳腺上皮细胞(HMLE)中也上调,这个结果我们也通过乳腺癌组织芯片原位杂交得到了进一步验证。Although the role of long noncoding RNAs (lncRNAs) has been increasingly recognized in various physiological and pathological conditions, the potential roles of large numbers of lncRNAs in breast cancer are less understood. We investigated the expression profile of lncRNAs by RT-PCR and identified a set of lncRNAs that were differentially expressed in patient breast cancer tissues relative to normal breast tissues, respectively. Among them, AK023948 is up-regulated in breast cancer, and it is also up-regulated in breast cancer cell lines (MCF-7 and MDA-MB-231) compared to human breast epithelial cells (HMLE). In situ hybridization was further validated.

本实施例以AK023948作为靶基因,在靶基因上选择靶位点(如图5中A部分所示),设计AK023948-dual gRNA,AK023948-dual gRNA中两条gRNA的正义链的碱基序列分别为:This example uses AK023948 as the target gene, selects the target site on the target gene (as shown in part A in Figure 5), and designs AK023948-dual gRNA, the base sequences of the sense strands of the two gRNAs in AK023948-dual gRNA are respectively for:

AK023948-gRNA1(如SEQ ID No.12所示):AK023948-gRNA1 (as shown in SEQ ID No.12):

5’-GAGTTTTAGTCACCTATCTA-3’;5'-GAGTTTTAGTCACCTATCTA-3';

AK023948-gRNA2(如SEQ ID No.13所示):AK023948-gRNA2 (as shown in SEQ ID No.13):

5’-GGTGATCCTTGTGCACGGCC-3’;5'-GGTGATCCTTGTGCACGGCC-3';

采用与实施例3第(1)部分相同的方法,分别构建含hCas9和AK023948-dual gRNA的表达载体,并利用该表达载体转染目标细胞,分离KO克隆的基因组DNA进行PCR,检测KO克隆中AK023948基因的缺失情况(如图5中B部分所示);同时采用与实施例3第(2)部分相同的方法,分离KO克隆的总RNA,进行RT-PCR验证相应KO克隆中AK023948基因的缺失情况(如图5中C部分所示)。Using the same method as in Example 3 (1), construct expression vectors containing hCas9 and AK023948-dual gRNA respectively, and use the expression vectors to transfect target cells, isolate the genomic DNA of KO clones for PCR, and detect The deletion of the AK023948 gene (as shown in part B in Figure 5); while using the same method as in Example 3 (2), the total RNA of the KO clone was isolated, and RT-PCR was performed to verify the presence of the AK023948 gene in the corresponding KO clone. Missing situation (shown in part C in Figure 5).

由图5可见,采用本实施例双gRNA能够完全敲除AK023948基因。It can be seen from Figure 5 that the AK023948 gene can be completely knocked out by using the double gRNA of this embodiment.

Claims (10)

1. a kind of couple of gRNA, it is characterised in that by the first promoter, gRNA-a, crRNA branch Frame sequence, the second promoter and gRNA-b are sequentially connected with and formed.
2. a kind of pair of gRNA library, it is characterised in that this pair of gRNA library includes being directed to target base Multiple couples of gRNA of cause, described couple of gRNA sequential structure is:First promoter-(gRNA-na)- The promoter of crRNA stent sequences-the second-(gRNA-nb);
Wherein, n represents double gRNA number, and n is >=1 integer.
3. gRNA libraries as claimed in claim 2 double, it is characterised in that the first promoter and Second promoter is mutually different polymerase III promoter.
4. a kind of pair of gRNA vector library, it is characterised in that double as described in Claims 2 or 3 GRNA libraries are formed by connecting with carrier.
5. the construction method of double gRNA vector libraries as claimed in claim 4, it is characterised in that Including:
(1) for a double gRNA action site, composition sequence structure is " PCR expands short sequence The single stranded oligonucleotide that I- (gRNA-a)-intervening sequence-(gRNA-b)-PCR expands short sequence II " is arranged, Wherein, the two ends of intervening sequence carry the restriction enzyme site of II class restriction enzymes;
All single stranded oligonucleotide mixed in equal amounts that will be synthesized for same target gene, or, it will be directed to The single stranded oligonucleotide mixed in equal amounts of all target gene synthesis, obtains mixing single stranded oligonucleotide storehouse;
(2) using the mixing single stranded oligonucleotide storehouse in step (1) as template, corresponding primer is utilized Enter performing PCR amplification, obtain mixing double chain oligonucleotide storehouse;
(3) carrier of II classes of learning from else's experience restriction enzyme linearisation, the mixing in step (2) is double Chain oligonucleotide library is connected into the first promoter downstream of the carrier, obtains early stage library;
(4) composition sequence structure is " PCR expands short sequence I-crRNA stent sequences-the second and started Son-PCR expands short sequence II " single stranded oligonucleotide storehouse;
(5) using the single stranded oligonucleotide storehouse in step (4) as template, carried out using corresponding primer PCR is expanded, and obtains double chain oligonucleotide storehouse;
(6) in the presence of II class restriction enzymes, by Gibson construction from parts by step (5) In double chain oligonucleotide storehouse be connected into the early stage library in step (3), obtain described couple of gRNA Vector library.
6. the construction method of double gRNA vector libraries as claimed in claim 5, it is characterised in that In step (1) or step (4), the base sequence that the PCR expands short sequence I is:
5’-GTATGAGACCACTTGGATCC-3’;
The base sequence that the PCR expands short sequence II is:
5’-CCTTATTTTAACTTGCTATT-3’。
7. double applications of the gRNA vector libraries in gene knockout as claimed in claim 4.
8. application as claimed in claim 7, it is characterised in that the gene is lncRNA.
9. application as claimed in claim 8, it is characterised in that including:
1. for the lncRNA of sequence context, for the lncRNA two ends design gRNA-a and GRNA-b, builds double gRNA vector libraries, and using this pair of gRNA vector libraries transfection or feel Cell is contaminated, intracellular target lncRNA is knocked out;
2. for the lncRNA inserted with other genes or genetic elements in sequence, with the lncRNA In first extron and its upstream promoter as target spot, design gRNA-a and gRNA-b, Double gRNA vector libraries are built, and using this pair of gRNA vector libraries transfection or infection cell, it is right Intracellular target lncRNA is knocked out.
10. a kind of Knockout cells library for being used to study corresponding gene function, it is characterised in that It is as claimed in claim 4 double by the transfection into the stable cell for expressing Cas9 nucleases or infection What gRNA vector libraries were obtained.
CN201610312039.6A 2016-05-11 2016-05-11 Double gRNA, double gRNA libraries, double gRNA vector libraries and its preparation method and application Pending CN106967716A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610312039.6A CN106967716A (en) 2016-05-11 2016-05-11 Double gRNA, double gRNA libraries, double gRNA vector libraries and its preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610312039.6A CN106967716A (en) 2016-05-11 2016-05-11 Double gRNA, double gRNA libraries, double gRNA vector libraries and its preparation method and application

Publications (1)

Publication Number Publication Date
CN106967716A true CN106967716A (en) 2017-07-21

Family

ID=59334518

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610312039.6A Pending CN106967716A (en) 2016-05-11 2016-05-11 Double gRNA, double gRNA libraries, double gRNA vector libraries and its preparation method and application

Country Status (1)

Country Link
CN (1) CN106967716A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107475292A (en) * 2017-08-02 2017-12-15 山东百福基因科技有限公司 The preparation method of the gene defection type T lymphocyte preparations of PD 1
CN107893086A (en) * 2017-10-24 2018-04-10 中国科学院武汉植物园 The method in rapid build pairing sgRNA Cas9 binary expression vectors library
CN108251451A (en) * 2018-01-16 2018-07-06 西南大学 CRISPR/Cas9-gRNA target practices sequence pair, plasmid and its application of HTT
WO2019196717A1 (en) * 2018-04-13 2019-10-17 青岛清原化合物有限公司 Randomly mutated gene editing system and use thereof
EP3578658A1 (en) * 2018-06-08 2019-12-11 Johann Wolfgang Goethe-Universität Frankfurt Method for generating a gene editing vector with fixed guide rna pairs
CN112522255A (en) * 2020-02-10 2021-03-19 南京启真基因工程有限公司 CRISPR/Cas9 system and application thereof in construction of porcine recombinant cell with insulin receptor substrate gene defect
CN112538497A (en) * 2019-09-20 2021-03-23 南京启真基因工程有限公司 CRISPR/Cas9 system and application thereof in construction of alpha, beta and alpha & beta thalassemia model pig cell lines
CN118995830A (en) * 2024-10-24 2024-11-22 中国科学院海洋研究所 Dmrt1 and sox9a double-gene mutant and preparation method and application thereof
WO2024254193A1 (en) * 2023-06-06 2024-12-12 Generate Biomedicines, Inc. Tandem guide agents and compositions and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150225730A1 (en) * 2014-02-12 2015-08-13 Dna2.0, Inc. Methods for generating libraries with co-varying regions of polynuleotides for genome modification

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150225730A1 (en) * 2014-02-12 2015-08-13 Dna2.0, Inc. Methods for generating libraries with co-varying regions of polynuleotides for genome modification

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TSUI-TING HO ET AL.: "Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines", 《NUCLEIC ACIDS RES》 *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107475292A (en) * 2017-08-02 2017-12-15 山东百福基因科技有限公司 The preparation method of the gene defection type T lymphocyte preparations of PD 1
CN107893086B (en) * 2017-10-24 2021-09-03 中国科学院武汉植物园 Method for rapidly constructing Cas9 binary expression vector library of paired sgRNAs
CN107893086A (en) * 2017-10-24 2018-04-10 中国科学院武汉植物园 The method in rapid build pairing sgRNA Cas9 binary expression vectors library
CN108251451A (en) * 2018-01-16 2018-07-06 西南大学 CRISPR/Cas9-gRNA target practices sequence pair, plasmid and its application of HTT
WO2019196717A1 (en) * 2018-04-13 2019-10-17 青岛清原化合物有限公司 Randomly mutated gene editing system and use thereof
CN110373430A (en) * 2018-04-13 2019-10-25 青岛清原化合物有限公司 A kind of the gene editing system and its application of random mutation
EP3578658A1 (en) * 2018-06-08 2019-12-11 Johann Wolfgang Goethe-Universität Frankfurt Method for generating a gene editing vector with fixed guide rna pairs
CN112538497A (en) * 2019-09-20 2021-03-23 南京启真基因工程有限公司 CRISPR/Cas9 system and application thereof in construction of alpha, beta and alpha & beta thalassemia model pig cell lines
CN112538497B (en) * 2019-09-20 2023-02-28 南京启真基因工程有限公司 CRISPR/Cas9 system and application thereof in construction of alpha, beta and alpha & beta thalassemia model pig cell lines
CN112522255A (en) * 2020-02-10 2021-03-19 南京启真基因工程有限公司 CRISPR/Cas9 system and application thereof in construction of porcine recombinant cell with insulin receptor substrate gene defect
CN112522255B (en) * 2020-02-10 2021-07-20 南京启真基因工程有限公司 CRISPR/Cas9 system and application thereof in construction of porcine recombinant cell with insulin receptor substrate gene defect
WO2024254193A1 (en) * 2023-06-06 2024-12-12 Generate Biomedicines, Inc. Tandem guide agents and compositions and uses thereof
CN118995830A (en) * 2024-10-24 2024-11-22 中国科学院海洋研究所 Dmrt1 and sox9a double-gene mutant and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN106967716A (en) Double gRNA, double gRNA libraries, double gRNA vector libraries and its preparation method and application
CN107502608B (en) Construction method and application of sgRNA for knocking out human ALDH2 gene and ALDH2 gene deletion cell line
CN104651399B (en) A method of gene knockout being realized in Pig embryos cell using CRISPR/Cas system
Yamamoto et al. Heterogeneity of Arabidopsis core promoters revealed by high‐density TSS analysis
US11898270B2 (en) Pig genome-wide specific sgRNA library, preparation method therefor and application thereof
Mica et al. High throughput approaches reveal splicing of primary microRNA transcripts and tissue specific expression of mature microRNAs in Vitis vinifera
CN106191057A (en) A kind of for knocking out the sgRNA sequence of people's CYP2E1 gene, the construction method of CYP2E1 gene delection cell strain and application thereof
CN107893080A (en) A kind of sgRNA for targetting rat Inhba genes and its application
Jiang et al. Small indels induced by CRISPR/Cas9 in the 5′ region of microRNA lead to its depletion and Drosha processing retardance
CN104651401A (en) Method for knocking out two mir-505 alleles
CN112384620B (en) Methods for screening and identifying functional lncRNA
CN104212836A (en) Method for knocking out mir-505 from mammal cell line
Hu et al. Phytophthora infestans Ago1‐associated miRNA promotes potato late blight disease
CN110343724A (en) Method for screening and identifying functional lncRNA
CN105950625A (en) sgRNA pair for conducting specific recognition on pig MSTN gene promoter and encoding DNA and application thereof
CN101935670B (en) A method for constructing RNA interference vector by direct annealing of multiple primers
Mica et al. Erratum to: high throughput approaches reveal splicing of primary microRNA transcripts and tissue specific expression of mature microRNAs in Vitis vinifera
Lee et al. An effective and rapid method for RNA preparation from non-conventional yeast species
CN113151265A (en) Method for inhibiting expression of lncRNA in nucleus based on CRISPR-dCase9 system
CN116555334A (en) Regulatory mechanism and application of ascorbic acid content in kiwi fruit
CN110229816B (en) Construction method and application of sgRNA for knocking out RBP4 gene, RBP4 gene deletion cell line
CN104195153B (en) A kind of Bicistronic mRNA coexpression gene transporter and preparation method
CN104059910B (en) A miRNA that Regulates the Expression of Anti-rust Fungus Infection Gene in Populus nigra
Panda et al. Structural and Functional Characterization of Circular RNAs
Seth The mysterious circle: Molecular curiosities of RNA mediated gene regulation

Legal Events

Date Code Title Description
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170721